Episode Details

In the latest TDR Cannabis in Five presented by Flowhub, Shadd Dales breaks down an important update on the lawsuit tied to the Medicare pilot program for hemp-derived cannabinoid products.This is a story we’ve been following — and now the federal government has officially responded.Robert F. Kennedy Jr. and Dr. Mehmet Oz are asking the court to dismiss the lawsuit brought forward by Smart Approaches to Marijuana (SAM). Their argument is simple — the groups behind the case aren’t directly affected by the program, which means they may not have the legal standing needed to move forward.If the court agrees, the case could be shut down early.But the bigger picture here is what this program represents.The proposed Medicare pilot would allow eligible patients to access hemp-derived cannabinoid products, including CBD and low-dose THC, with potential annual coverage.That’s a meaningful shift — because it brings cannabinoid-based products into a federal healthcare framework.At the same time, there are still questions around regulation, product standards, and how this fits within existing federal policy.So while this is still early — it’s something the industry should be paying attention to.Bottom line — this case could determine how quickly cannabinoid products move into healthcare conversations at the federal level.#CannabisNews #CBD #THC #CannabisPolicy #Healthcare #Medicare #CannabisIndustry #TDR #CannabisStocks #LegalNewsWant to see more Cannabis Reform videos?🎬    • Cannabis Rescheduling Isn’t Delayed It Jus...  🎬    • How Media Gets the Cannabis Youth Conversa...  🎬    • Idaho Lawmakers Fighting to Keep Medical C...  🎬    • Missouri Moves to Ban Hemp THC Products | ...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:

Listen Now